Monoamliines in tieBrainCerebrospinal Fluid of Facial Pain Patents

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• "Serotonin depression"--a biochemical subgroup within the affective disorders?

  2003cited by this paper
• Pimozide therapy for trigeminal neuralgia.

  1989cited by this paper
• Serotonergic mediation of spinal analgesia and its interaction with noradrenergic systems.

  1988cited by this paper
• Biochemical hypotheses on antidepressant drugs: a guide for clinicians or a toy for pharmacologists?

  1988cited by this paper
• Norepinephrine and its metabolites in cerebrospinal fluid, plasma, and urine. Relationship to hypothalamic-pituitary-adrenal axis function in depression.

  1988cited by this paper
• Concentration gradient of CSF monoamine metabolites in children and adolescents.

  1988cited by this paper
• Affect and pain: Neurochemical mediators and therapeutic approaches

  1987cited by this paper
• Biogenic amine and metabolite levels in depressed patients with high versus normal hypothalamic-pituitary-adrenocortical activity.

  1987cited by this paper
• 5-HIAA and HVA in CSF in patients with idiopathic pain disorders.

  1987cited by this paper
• CSF monoamine metabolites in chronic pain

  1987cited by this paper
• Reduced CSF concentrations of homovanillic acid and homovanillic acid to 5-hydroxyindoleacetic acid ratios in depressed patients: relationship to suicidal behavior and dexamethasone nonsuppression.

  1986cited by this paper
• Ventricular Size and CSF Transmitter Metabolite Concentrations in Severe Endogenous Depression

  1986cited by this paper
• Neurotransmission and the experience of low back pain; no association between csf monoamine metabolites and pain

  1985cited by this paper
• Hypoalgesia induced by the local injection of phentolamine in the nucleus raphe magnus: Blockade by depletion of spinal cord monoamines

  1983cited by this paper
• Monoamine metabolites in CSF and suicidal behavior.

  1981cited by this paper
• Serotonergic Activity in Man as a Function of Pain, Pain Mechanisms, and Depression

  1981cited by this paper
• Biological markers in major depressive disorders : a clinical and multivariate study

  1981cited by this paper
• Tryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid in human cerebrospinal fluid: interrelationships and the influence of age, sex, epilepsy and anticonvulsant drugs.

  1980cited by this paper
• SUBSTANCES RELATED TO 5‐HYDROXYTRYPTAMINE IN PLASMA AND IN LUMBAR AND VENTRICULAR FLUIDS OF PSYCHIATRIC PATIENTS

  1980cited by this paper
• Endogenous pain control mechanisms

  1979cited by this paper
• Transmitter precursors and metabolites in human ventricular cerebrospinal fluid

  1976cited by this paper
• Gradients of biogenic amine metabolites in cerebrospinal fluid.

  1975cited by this paper
• Monoaminergic mechanisms of stimulation‐produced analgesia

  1975cited by this paper
• Analgesia from electrical stimulation of the periaqueductal gray matter in the cat: behavioral observations and inhibitory effects on spinal cord interneurons.

  1973cited by this paper
• Sites of origin in the central nervous system of monoamine metabolites measured in human cerebrospinal fluid1

  1973cited by this paper
• Is cerebrospinal fluid the major avenue for the removal of 5-hydroxyindoleacetic acid from the brain?

  1973cited by this paper
• Amine metabolites in the lumbar cerebrospinal fluid of humans with restricted flow of cerebrospinal fluid.

  1971cited by this paper
• Homovanillic and 5-hydroxyindoleacetic acid in cerebrospinal fluid of depressed patients.

  1971cited by this paper
• Cerebral metabolites in cerebrospinal fluid as a biochemical approach to the brain.

  1970cited by this paper
• HOMOVANILLIC ACID AND 5‐HYDROXYINDOLEACETIC ACID IN THE CEREBROSPINAL FLUID OF PATIENTS WITH SENILE DEMENTIA, PRESENILE DEMENTIA AND PARKINSONISM

  1969cited by this paper
• 5-hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases.

  1966cited by this paper

• No citing papers are available for this paper.